GDNF and amyotrophic lateral sclerosis: Proceeding beyond this strategy, stem cells can also be engineered to secrete selected molecules at the disease site [16]; human neural progenitor cells (hNPCs) modified by using lentivirus to secrete glial cell-derived neurotrophic factor (GDNF) integrated properly within ALS animal models.